Home → Focus

Fentanyl is the deadliest drug in America, CDC confirms Print E-mail
Written by Nadia Kounang, CNN   
Thursday, 13 December 2018 00:00
Fentanyl is now the most commonly used drug involved in drug overdoses, according to a new government report. The latest numbers from the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics say that the rate of drug overdoses involving the synthetic opioid skyrocketed by about 113% each year from 2013 through 2016. The number of total drug overdoses jumped 54% each year between 2011 and 2016. In 2016, there were 63,632 drug overdose deaths. According to Wednesday's report, which analyzed death certificates for drug overdose deaths between 2011 and 2016, fentanyl was involved in nearly 29% of all overdose deaths in 2016. In 2011, fentanyl was involved in just 4% of all drug fatalities.

Last Updated on Friday, 14 December 2018 17:58
Investigation of generic 'cartel' expands to 300 drugs Print E-mail
Written by FHInews   
Tuesday, 11 December 2018 19:01
Chistopher Rowland reports, for the Washington Post on 12.9.18, about a case involving the generic pharmaceutical industry that is rapidly gaining steam. Investigators are looking into executives at more than a dozen generic-drug  companies over a massive price-fixing scheme, in what is being called potentially the largest U.S. drug cartel. The investigation reportedly began in 2016, in response to a complaint filed by states against two drugs. The ring of pharmaceutical companies has allegedly overcharged consumers and taxpayers for common drugs ranging from antibiotics to anxiety pills to asthma medication, authorities said. The effects have rippled throughout the health care sector, also affecting hospitals and insurance companies.

Read the Washington Post story HERE.
(Warning: Paywall may apply.)

Fox News does a nice summary of the WaPo article HERE.
(No paywall.)

Last Updated on Tuesday, 11 December 2018 19:05
AHA, AAMC sue Trump administration over site-neutral payment rule Print E-mail
Written by Tina Reed | Fierce Healthcare   
Wednesday, 05 December 2018 00:00
Two of the nation's largest healthcare groups are suing the Trump administration over a final rule to institute site-neutral payments for clinic visits, saying the policy would hurt patients. Last month, the Centers for Medicare & Medicaid Services (CMS) finalized the 2019 Outpatient Prospective Payment System (OPPS) rule, which will gradually institute site-neutral payments in the Medicare program over the next two years. Agency officials said site-neutral payments for clinic visits will lower out-of-pocket costs for beneficiaries and save the program as much as $380 million in 2019. In a complaint filed in the U.S. District Court for the District of Columbia, the American Hospital Association (AHA) and the Association of American Medical Colleges (AAMC) said the rule would lead to access problems as hospitals cut services, hurting vulnerable patients. The associations claimed the administration is overstepping its legal bounds and were joined in the legal action by Olympic Medical Center in Port Angeles, Washington; Mercy Health in Muskegon, Michigan; and York Hospital in York, Maine.

Last Updated on Friday, 07 December 2018 18:44
FIU’s Nicole Wertheim College of Nursing & Health Sciences Launches First Doctor of Athletic Training Program in the Southeast U.S. Print E-mail
Written by FHInews   
Tuesday, 27 November 2018 00:00
Dr. Shawn Felton appointed as new chair of the Department of Athletic Training

Miami based Florida International University’s (FIU) Nicole Wertheim College of Nursing and Health Sciences has introduced the first Doctor of Athletic Training (DAT) program in the southeast U.S. Clinical Associate Professor Shawn Dale Felton, EdD, ATC, LAT, was appointed as the new chair of the Department of Athletic Training to oversee the launch of the DAT program, which is one of only six in the country.

The DAT program is the academic progression of the Athletic Training profession toward higher levels of clinical, evidence-based practice, research and leadership. The goals of the program are to develop athletic trainers who actively contribute to expanding their skills, knowledge and clinical abilities through applied research. Students will apply advanced clinical skills to improve patient outcomes, and proactively develop and implement injury and illness prevention strategies to become health care innovators.

Dr. Felton succeeds founding FIU Athletic Training chair Jennifer Doherty-Restrepo, PhD, ATC, LAT, who spearheaded the establishment of the DAT. He joins FIU having most recently been a faculty member in the Department of Rehabilitation Sciences at Florida Gulf Coast University, where he served on the Board of Trustees and as president of the faculty senate.

Dr. Felton’s professional academic and clinical career began as a graduate assistant at the University of Louisville in 2001, serving as an assistant football athletic trainer directing the comprehensive medical care of more than 110 student athletes. He was also the athletic training coordinator for Naples Community Hospitals (2004-2005) supervising a staff of nine individuals to provide athletic training to Collier County Public Schools.

“Dr. Felton’s administrative leadership experience, clinical expertise and body of research will build on the foundation Dr. Doherty-Restrepo set to drive FIU Athletic Training to national prominence and provide our students with the highest-level of education and research opportunities to excel in their careers,” said Ora L Strickland, PhD, DSc (Hon.), RN, FAAN, Dean of the Nicole Wertheim College of Nursing and Health Sciences.

The FIU Athletic Training department will continue to offer the Master of Science in Athletic Training along with the DAT. For more information on the DAT program, visit

Last Updated on Friday, 30 November 2018 12:01
CDC Reports Record Low Smoking Rates in the U.S. Print E-mail
Written by FHI's Week in Review   
Monday, 12 November 2018 14:18 reports on Nov. 8, 2018:

Cigarette smoking has reached the lowest level ever recorded among U.S. adults, according to new data published by the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and the National Institutes of Health's National Cancer Institute (NCI). Still, about 47 million (1 in 5) U.S. adults used a tobacco product in 2017, and they used a variety of smoked, smokeless, and electronic tobacco products. An estimated 14 percent of U.S. adults (34 million) were current ("every day" or "some day") cigarette smokers in 2017-down from 15.5 in 2016-a 67 percent decline since 1965. A particularly notable decline occurred among young adults between 2016 and 2017: about 10 percent of young adults aged 18 to 24 years smoked cigarettes in 2017, down from 13 percent in 2016.
Read more in the current issue of Week in Review>>
Last Updated on Monday, 12 November 2018 14:22
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 1 of 129

Website design, development, and hosting provided by